Contact
Country: Czech Republic
Investment type: Ownership Transition
Fund: EVERITA Fund I
Industry: Healthcare
Date of initial investment: 2026
Current ownership stake: 80%
Clintrial is a Prague-based clinical trial center founded in 2005, specialising in Phase Il and Phase Ill trials across four therapeutic areas: psychiatry, neurology, dermatology, and rheumatology. The company has participated in more than 100 clinical trials and has enrolled more than 1,000 patients in studies. Clintrial employs more than 30 qualified professionals and works with a network of specialist physicians across the Czech Republic.
have signed a strategic partnership agreement under which EVERITA Capital and group of co-investors has acquired a 80% ownership stake.